On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
George is the cofounder and managing director of Sixfold Bioscience, a Y Combinator backed biotech that utilises advanced nanoengineering to create safer and more targeted systems for the delivery of RNA therapies. Sixfold’s Mergo™ platform has been designed from the bottom-up to overcome some major limitations of traditional drug delivery systems and unlock treatments for potentially thousands of diseases. Prior to Sixfold, George completed his PhD at Cambridge University where he implemented novel methods for the visualisation of nano-structures in complex cellular models. In this talk George will present a short overview of his career, life at a startup, how to attract funding and building a multidisciplinary team from scratch.
